secwatch / observer
8-K filed February 28, 2025, 6:59 PM ET ticker SKIN CIK 0001818093
leadership confidence high sentiment neutral materiality 0.50

Beauty Health designates Menezes, Lewis as executive officers; discloses compensation

SkinHealth Systems Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Ronald Menezes

Chief Revenue Officer
SKIN · SkinHealth Systems Inc.
Effective
2025-02-25
Filed
February 28, 2025, 6:59 PM ET
Due to this determination, the Board designated Mr. Menezes as an executive officer, as that term is defined in 17 C.F.R. § 240.3b-7 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), thus making Mr. Menezes an executive officer subject to Section 16 of the Exchange Act (a "Section 16 Officer").

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronald Menezes changed role as Chief Revenue Officer at SkinHealth Systems Inc..

Action
designated
Role
Chief Revenue Officer
Exact text from the filing
Due to this determination, the Board designated Mr. Menezes as an executive officer, as that term is defined in 17 C.F.R. § 240.3b-7 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), thus making Mr. Menezes an executive officer subject to Section 16 of the Exchange Act (a "Section 16 Officer").
View on SEC.gov

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR
accession 0001628280-25-009050
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.